SPY412.27-3.80 -0.91%
DIA338.12-3.18 -0.93%
IXIC13,818.41-131.81 -0.94%

RBC Capital Maintains Sector Perform on Aprea Therapeutics, Lowers Price Target to $8

RBC Capital analyst Gregory Renza maintains Aprea Therapeutics (NASDAQ:APRE) with a Sector Perform and lowers the price target from $10 to $8.

· 03/17/2021 07:49
RBC Capital analyst Gregory Renza maintains Aprea Therapeutics (NASDAQ:APRE) with a Sector Perform and lowers the price target from $10 to $8.